Biogen’s Alzheimer’s drug: What’s the price tag on hope?
World of DTC Marketing
JUNE 1, 2021
The first clinic; trials were everything but encouraging but so much depend ended on this drug’s approval that Biogen returned and recited the data. Biogen concluded the key to effectiveness was giving patients a high-enough dose, but critics howled, with one calling the analysis “a post hoc dumpster dive operation.”
Let's personalize your content